异基因造血细胞移植后急性髓系白血病复发的强化化疗。 - Suppr

Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.

作者信息

Krakow Elizabeth F, Walter Roland B, Nathe Julia M, Perez Tess, Ahmed Ali, Polissar Nayak, Miljacic Ljubomir, Halpern Anna B, Flowers Mary E D, Estey Eli

机构信息

Clinical Research Division of the Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Division of Medical Oncology, University of Washington, Seattle, WA, USA.

出版信息

Am J Hematol. 2022 Jun 1;97(6):E220-E223. doi: 10.1002/ajh.26540. Epub 2022 Mar 28.

DOI:10.1002/ajh.26540

PMID:35303371

Abstract

摘要

相似文献

Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后急性髓系白血病复发的强化化疗。

Am J Hematol. 2022 Jun 1;97(6):E220-E223. doi: 10.1002/ajh.26540. Epub 2022 Mar 28.

Conditioning regimens in acute myeloid leukemia.

Expert Rev Hematol. 2014 Aug;7(4):465-79. doi: 10.1586/17474086.2014.939066.

[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].[采用FLAG序贯白消安/环磷酰胺预处理方案进行异基因造血干细胞移植治疗难治/复发急性髓系白血病的临床结局]

Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008.

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.老年急性髓系白血病患者的强化化疗及减低强度异基因造血干细胞移植

Asia Pac J Clin Oncol. 2014 Sep;10(3):246-54. doi: 10.1111/ajco.12188. Epub 2014 Mar 27.

Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.伊达比星强化的BUCY2预处理方案改善了接受异基因造血干细胞移植的高危急性髓系白血病患者的生存率，但对淋巴细胞白血病患者无效：一项回顾性比较研究。

Leuk Res. 2016 Jul;46:61-8. doi: 10.1016/j.leukres.2016.04.014. Epub 2016 Apr 19.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.60岁及以上急性髓系白血病患者异基因干细胞移植缓解后治疗：一项时间依赖性分析

Lancet Haematol. 2015 Oct;2(10):e427-36. doi: 10.1016/S2352-3026(15)00148-9. Epub 2015 Sep 18.

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.单倍体核型作为首次完全缓解期接受异基因造血干细胞移植治疗的急性髓系白血病患者的不良预后因素：代表欧洲血液与骨髓移植协会急性白血病工作组进行的一项回顾性调查

Haematologica. 2016 Feb;101(2):248-55. doi: 10.3324/haematol.2015.132654. Epub 2015 Nov 20.

Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study.干扰素-α 对异基因造血干细胞移植后 t(8;21) 急性髓系白血病患者微小残留病的治疗有效：一项前瞻性登记研究的结果。

Oncologist. 2018 Nov;23(11):1349-1357. doi: 10.1634/theoncologist.2017-0692. Epub 2018 Aug 3.

Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.异基因造血细胞移植后治疗急性髓系白血病的维持治疗。

Best Pract Res Clin Haematol. 2019 Dec;32(4):101109. doi: 10.1016/j.beha.2019.101109. Epub 2019 Oct 18.

引用本文的文献

IFN-γ and donor leukocyte infusions for relapsed myeloblastic malignancies after allogeneic hematopoietic stem cell transplantation.干扰素-γ与供体白细胞输注用于异基因造血干细胞移植后复发的髓母细胞性恶性肿瘤

JCI Insight. 2025 Mar 25;10(9). doi: 10.1172/jci.insight.190655. eCollection 2025 May 8.

Maintenance strategies for relapse prevention and treatment.预防复发和治疗的维持策略。

Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):635-643. doi: 10.1182/hematology.2024000589.

Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Venetoclax 联合低甲基化药物治疗异基因造血干细胞移植后急性髓系白血病和骨髓增生异常综合征复发的疗效和安全性：系统评价和荟萃分析。

BMC Cancer. 2023 Aug 17;23(1):764. doi: 10.1186/s12885-023-11259-6.

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT.维奈克拉联合去甲基化药物与强化化疗用于异基因造血干细胞移植后髓系恶性肿瘤血液学复发的治疗比较

Front Oncol. 2023 Mar 23;13:1137175. doi: 10.3389/fonc.2023.1137175. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献